Global Anti-tumor Drug Market Growth (Status and Outlook) 2023-2029

Anti-tumor drugs are for the treatment of cancer diseases. In recent years, the development of molecular oncology and molecular pharmacology has gradually clarified the nature of the tumor. The invention and application of advanced technologies such as large-scale rapid screening, combinatorial chemistry and genetic engineering have accelerated the process of drug development. The research and development of anti-tumor drugs have been into a new era.

LPI (LP Information)' newest research report, the “Anti-tumor Drug Industry Forecast” looks at past sales and reviews total world Anti-tumor Drug sales in 2022, providing a comprehensive analysis by region and market sector of projected Anti-tumor Drug sales for 2023 through 2029. With Anti-tumor Drug sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Anti-tumor Drug industry.

This Insight Report provides a comprehensive analysis of the global Anti-tumor Drug landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Anti-tumor Drug portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Anti-tumor Drug market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Anti-tumor Drug and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Anti-tumor Drug.

The global Anti-tumor Drug market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

In China, Anti-tumor Drug key players include AstraZeneca, Merck & Co., Roche, Celgene, Johnson & Johnson, etc.

United States is the largest market, followed by Japan, and Europe.

This report presents a comprehensive overview, market shares, and growth opportunities of Anti-tumor Drug market by product type, application, key players and key regions and countries.

Market Segmentation:
Segmentation by type
    Cytotoxic Drugs
    Non-cytotoxic Drugs

Segmentation by application
    Alkylating Agents
    Anti-Metabolism Drugs
    Platinum Antineoplastic Agents
    Anthracycline Antitumor Drugs
    Microtubule Stabilizer
    Endocrine Therapy Drugs
    Immunotherapy Drugs
    Gene Therapy Drugs
    Targeted Antineoplastic Drugs

This report also splits the market by region:
    Americas
        United States
        Canada
        Mexico
        Brazil
    APAC
        China
        Japan
        Korea
        Southeast Asia
        India
        Australia
    Europe
        Germany
        France
        UK
        Italy
        Russia
    Middle East & Africa
        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
    Roche
    Novartis
    Celgene
    Bristol-Myers Squibb
    Amgen
    Johnson & Johnson
    Pfizer
    Takeda
    Eli Lilly
    AstraZeneca
    Astellas
    Merck & Co
    Sanofi
    Bayer
    Biogen Idec
    Eisai
    Teva
    Otsuka

List of Tables
    Table 1. Anti-tumor Drug Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
    Table 2. Major Players of Cytotoxic Drugs
    Table 3. Major Players of Non-cytotoxic Drugs
    Table 4. Anti-tumor Drug Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
    Table 5. Global Anti-tumor Drug Market Size by Type (2018-2023) & ($ Millions)
    Table 6. Global Anti-tumor Drug Market Size Market Share by Type (2018-2023)
    Table 7. Anti-tumor Drug Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
    Table 8. Global Anti-tumor Drug Market Size by Application (2018-2023) & ($ Millions)
    Table 9. Global Anti-tumor Drug Market Size Market Share by Application (2018-2023)
    Table 10. Global Anti-tumor Drug Revenue by Players (2018-2023) & ($ Millions)
    Table 11. Global Anti-tumor Drug Revenue Market Share by Player (2018-2023)
    Table 12. Anti-tumor Drug Key Players Head office and Products Offered
    Table 13. Anti-tumor Drug Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
    Table 14. New Products and Potential Entrants
    Table 15. Mergers & Acquisitions, Expansion
    Table 16. Global Anti-tumor Drug Market Size by Regions 2018-2023 & ($ Millions)
    Table 17. Global Anti-tumor Drug Market Size Market Share by Regions (2018-2023)
    Table 18. Global Anti-tumor Drug Revenue by Country/Region (2018-2023) & ($ millions)
    Table 19. Global Anti-tumor Drug Revenue Market Share by Country/Region (2018-2023)
    Table 20. Americas Anti-tumor Drug Market Size by Country (2018-2023) & ($ Millions)
    Table 21. Americas Anti-tumor Drug Market Size Market Share by Country (2018-2023)
    Table 22. Americas Anti-tumor Drug Market Size by Type (2018-2023) & ($ Millions)
    Table 23. Americas Anti-tumor Drug Market Size Market Share by Type (2018-2023)
    Table 24. Americas Anti-tumor Drug Market Size by Application (2018-2023) & ($ Millions)
    Table 25. Americas Anti-tumor Drug Market Size Market Share by Application (2018-2023)
    Table 26. APAC Anti-tumor Drug Market Size by Region (2018-2023) & ($ Millions)
    Table 27. APAC Anti-tumor Drug Market Size Market Share by Region (2018-2023)
    Table 28. APAC Anti-tumor Drug Market Size by Type (2018-2023) & ($ Millions)
    Table 29. APAC Anti-tumor Drug Market Size Market Share by Type (2018-2023)
    Table 30. APAC Anti-tumor Drug Market Size by Application (2018-2023) & ($ Millions)
    Table 31. APAC Anti-tumor Drug Market Size Market Share by Application (2018-2023)
    Table 32. Europe Anti-tumor Drug Market Size by Country (2018-2023) & ($ Millions)
    Table 33. Europe Anti-tumor Drug Market Size Market Share by Country (2018-2023)
    Table 34. Europe Anti-tumor Drug Market Size by Type (2018-2023) & ($ Millions)
    Table 35. Europe Anti-tumor Drug Market Size Market Share by Type (2018-2023)
    Table 36. Europe Anti-tumor Drug Market Size by Application (2018-2023) & ($ Millions)
    Table 37. Europe Anti-tumor Drug Market Size Market Share by Application (2018-2023)
    Table 38. Middle East & Africa Anti-tumor Drug Market Size by Region (2018-2023) & ($ Millions)
    Table 39. Middle East & Africa Anti-tumor Drug Market Size Market Share by Region (2018-2023)
    Table 40. Middle East & Africa Anti-tumor Drug Market Size by Type (2018-2023) & ($ Millions)
    Table 41. Middle East & Africa Anti-tumor Drug Market Size Market Share by Type (2018-2023)
    Table 42. Middle East & Africa Anti-tumor Drug Market Size by Application (2018-2023) & ($ Millions)
    Table 43. Middle East & Africa Anti-tumor Drug Market Size Market Share by Application (2018-2023)
    Table 44. Key Market Drivers & Growth Opportunities of Anti-tumor Drug
    Table 45. Key Market Challenges & Risks of Anti-tumor Drug
    Table 46. Key Industry Trends of Anti-tumor Drug
    Table 47. Global Anti-tumor Drug Market Size Forecast by Regions (2024-2029) & ($ Millions)
    Table 48. Global Anti-tumor Drug Market Size Market Share Forecast by Regions (2024-2029)
    Table 49. Global Anti-tumor Drug Market Size Forecast by Type (2024-2029) & ($ Millions)
    Table 50. Global Anti-tumor Drug Market Size Forecast by Application (2024-2029) & ($ Millions)
    Table 51. Roche Details, Company Type, Anti-tumor Drug Area Served and Its Competitors
    Table 52. Roche Anti-tumor Drug Product Offered
    Table 53. Roche Anti-tumor Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
    Table 54. Roche Main Business
    Table 55. Roche Latest Developments
    Table 56. Novartis Details, Company Type, Anti-tumor Drug Area Served and Its Competitors
    Table 57. Novartis Anti-tumor Drug Product Offered
    Table 58. Novartis Main Business
    Table 59. Novartis Anti-tumor Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
    Table 60. Novartis Latest Developments
    Table 61. Celgene Details, Company Type, Anti-tumor Drug Area Served and Its Competitors
    Table 62. Celgene Anti-tumor Drug Product Offered
    Table 63. Celgene Main Business
    Table 64. Celgene Anti-tumor Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
    Table 65. Celgene Latest Developments
    Table 66. Bristol-Myers Squibb Details, Company Type, Anti-tumor Drug Area Served and Its Competitors
    Table 67. Bristol-Myers Squibb Anti-tumor Drug Product Offered
    Table 68. Bristol-Myers Squibb Main Business
    Table 69. Bristol-Myers Squibb Anti-tumor Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
    Table 70. Bristol-Myers Squibb Latest Developments
    Table 71. Amgen Details, Company Type, Anti-tumor Drug Area Served and Its Competitors
    Table 72. Amgen Anti-tumor Drug Product Offered
    Table 73. Amgen Main Business
    Table 74. Amgen Anti-tumor Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
    Table 75. Amgen Latest Developments
    Table 76. Johnson & Johnson Details, Company Type, Anti-tumor Drug Area Served and Its Competitors
    Table 77. Johnson & Johnson Anti-tumor Drug Product Offered
    Table 78. Johnson & Johnson Main Business
    Table 79. Johnson & Johnson Anti-tumor Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
    Table 80. Johnson & Johnson Latest Developments
    Table 81. Pfizer Details, Company Type, Anti-tumor Drug Area Served and Its Competitors
    Table 82. Pfizer Anti-tumor Drug Product Offered
    Table 83. Pfizer Main Business
    Table 84. Pfizer Anti-tumor Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
    Table 85. Pfizer Latest Developments
    Table 86. Takeda Details, Company Type, Anti-tumor Drug Area Served and Its Competitors
    Table 87. Takeda Anti-tumor Drug Product Offered
    Table 88. Takeda Main Business
    Table 89. Takeda Anti-tumor Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
    Table 90. Takeda Latest Developments
    Table 91. Eli Lilly Details, Company Type, Anti-tumor Drug Area Served and Its Competitors
    Table 92. Eli Lilly Anti-tumor Drug Product Offered
    Table 93. Eli Lilly Main Business
    Table 94. Eli Lilly Anti-tumor Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
    Table 95. Eli Lilly Latest Developments
    Table 96. AstraZeneca Details, Company Type, Anti-tumor Drug Area Served and Its Competitors
    Table 97. AstraZeneca Anti-tumor Drug Product Offered
    Table 98. AstraZeneca Main Business
    Table 99. AstraZeneca Anti-tumor Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
    Table 100. AstraZeneca Latest Developments
    Table 101. Astellas Details, Company Type, Anti-tumor Drug Area Served and Its Competitors
    Table 102. Astellas Anti-tumor Drug Product Offered
    Table 103. Astellas Anti-tumor Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
    Table 104. Astellas Main Business
    Table 105. Astellas Latest Developments
    Table 106. Merck & Co Details, Company Type, Anti-tumor Drug Area Served and Its Competitors
    Table 107. Merck & Co Anti-tumor Drug Product Offered
    Table 108. Merck & Co Main Business
    Table 109. Merck & Co Anti-tumor Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
    Table 110. Merck & Co Latest Developments
    Table 111. Sanofi Details, Company Type, Anti-tumor Drug Area Served and Its Competitors
    Table 112. Sanofi Anti-tumor Drug Product Offered
    Table 113. Sanofi Main Business
    Table 114. Sanofi Anti-tumor Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
    Table 115. Sanofi Latest Developments
    Table 116. Bayer Details, Company Type, Anti-tumor Drug Area Served and Its Competitors
    Table 117. Bayer Anti-tumor Drug Product Offered
    Table 118. Bayer Main Business
    Table 119. Bayer Anti-tumor Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
    Table 120. Bayer Latest Developments
    Table 121. Biogen Idec Details, Company Type, Anti-tumor Drug Area Served and Its Competitors
    Table 122. Biogen Idec Anti-tumor Drug Product Offered
    Table 123. Biogen Idec Main Business
    Table 124. Biogen Idec Anti-tumor Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
    Table 125. Biogen Idec Latest Developments
    Table 126. Eisai Details, Company Type, Anti-tumor Drug Area Served and Its Competitors
    Table 127. Eisai Anti-tumor Drug Product Offered
    Table 128. Eisai Main Business
    Table 129. Eisai Anti-tumor Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
    Table 130. Eisai Latest Developments
    Table 131. Teva Details, Company Type, Anti-tumor Drug Area Served and Its Competitors
    Table 132. Teva Anti-tumor Drug Product Offered
    Table 133. Teva Main Business
    Table 134. Teva Anti-tumor Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
    Table 135. Teva Latest Developments
    Table 136. Otsuka Details, Company Type, Anti-tumor Drug Area Served and Its Competitors
    Table 137. Otsuka Anti-tumor Drug Product Offered
    Table 138. Otsuka Main Business
    Table 139. Otsuka Anti-tumor Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
    Table 140. Otsuka Latest Developments
List of Figures
    Figure 1. Anti-tumor Drug Report Years Considered
    Figure 2. Research Objectives
    Figure 3. Research Methodology
    Figure 4. Research Process and Data Source
    Figure 5. Global Anti-tumor Drug Market Size Growth Rate 2018-2029 ($ Millions)
    Figure 6. Anti-tumor Drug Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
    Figure 7. Anti-tumor Drug Sales Market Share by Country/Region (2022)
    Figure 8. Anti-tumor Drug Sales Market Share by Country/Region (2018, 2022 & 2029)
    Figure 9. Global Anti-tumor Drug Market Size Market Share by Type in 2022
    Figure 10. Anti-tumor Drug in Alkylating Agents
    Figure 11. Global Anti-tumor Drug Market: Alkylating Agents (2018-2023) & ($ Millions)
    Figure 12. Anti-tumor Drug in Anti-Metabolism Drugs
    Figure 13. Global Anti-tumor Drug Market: Anti-Metabolism Drugs (2018-2023) & ($ Millions)
    Figure 14. Anti-tumor Drug in Platinum Antineoplastic Agents
    Figure 15. Global Anti-tumor Drug Market: Platinum Antineoplastic Agents (2018-2023) & ($ Millions)
    Figure 16. Anti-tumor Drug in Anthracycline Antitumor Drugs
    Figure 17. Global Anti-tumor Drug Market: Anthracycline Antitumor Drugs (2018-2023) & ($ Millions)
    Figure 18. Anti-tumor Drug in Microtubule Stabilizer
    Figure 19. Global Anti-tumor Drug Market: Microtubule Stabilizer (2018-2023) & ($ Millions)
    Figure 20. Anti-tumor Drug in Endocrine Therapy Drugs
    Figure 21. Global Anti-tumor Drug Market: Endocrine Therapy Drugs (2018-2023) & ($ Millions)
    Figure 22. Anti-tumor Drug in Immunotherapy Drugs
    Figure 23. Global Anti-tumor Drug Market: Immunotherapy Drugs (2018-2023) & ($ Millions)
    Figure 24. Anti-tumor Drug in Gene Therapy Drugs
    Figure 25. Global Anti-tumor Drug Market: Gene Therapy Drugs (2018-2023) & ($ Millions)
    Figure 26. Anti-tumor Drug in Targeted Antineoplastic Drugs
    Figure 27. Global Anti-tumor Drug Market: Targeted Antineoplastic Drugs (2018-2023) & ($ Millions)
    Figure 28. Global Anti-tumor Drug Market Size Market Share by Application in 2022
    Figure 29. Global Anti-tumor Drug Revenue Market Share by Player in 2022
    Figure 30. Global Anti-tumor Drug Market Size Market Share by Regions (2018-2023)
    Figure 31. Americas Anti-tumor Drug Market Size 2018-2023 ($ Millions)
    Figure 32. APAC Anti-tumor Drug Market Size 2018-2023 ($ Millions)
    Figure 33. Europe Anti-tumor Drug Market Size 2018-2023 ($ Millions)
    Figure 34. Middle East & Africa Anti-tumor Drug Market Size 2018-2023 ($ Millions)
    Figure 35. Americas Anti-tumor Drug Value Market Share by Country in 2022
    Figure 36. United States Anti-tumor Drug Market Size Growth 2018-2023 ($ Millions)
    Figure 37. Canada Anti-tumor Drug Market Size Growth 2018-2023 ($ Millions)
    Figure 38. Mexico Anti-tumor Drug Market Size Growth 2018-2023 ($ Millions)
    Figure 39. Brazil Anti-tumor Drug Market Size Growth 2018-2023 ($ Millions)
    Figure 40. APAC Anti-tumor Drug Market Size Market Share by Region in 2022
    Figure 41. APAC Anti-tumor Drug Market Size Market Share by Type in 2022
    Figure 42. APAC Anti-tumor Drug Market Size Market Share by Application in 2022
    Figure 43. China Anti-tumor Drug Market Size Growth 2018-2023 ($ Millions)
    Figure 44. Japan Anti-tumor Drug Market Size Growth 2018-2023 ($ Millions)
    Figure 45. Korea Anti-tumor Drug Market Size Growth 2018-2023 ($ Millions)
    Figure 46. Southeast Asia Anti-tumor Drug Market Size Growth 2018-2023 ($ Millions)
    Figure 47. India Anti-tumor Drug Market Size Growth 2018-2023 ($ Millions)
    Figure 48. Australia Anti-tumor Drug Market Size Growth 2018-2023 ($ Millions)
    Figure 49. Europe Anti-tumor Drug Market Size Market Share by Country in 2022
    Figure 50. Europe Anti-tumor Drug Market Size Market Share by Type (2018-2023)
    Figure 51. Europe Anti-tumor Drug Market Size Market Share by Application (2018-2023)
    Figure 52. Germany Anti-tumor Drug Market Size Growth 2018-2023 ($ Millions)
    Figure 53. France Anti-tumor Drug Market Size Growth 2018-2023 ($ Millions)
    Figure 54. UK Anti-tumor Drug Market Size Growth 2018-2023 ($ Millions)
    Figure 55. Italy Anti-tumor Drug Market Size Growth 2018-2023 ($ Millions)
    Figure 56. Russia Anti-tumor Drug Market Size Growth 2018-2023 ($ Millions)
    Figure 57. Middle East & Africa Anti-tumor Drug Market Size Market Share by Region (2018-2023)
    Figure 58. Middle East & Africa Anti-tumor Drug Market Size Market Share by Type (2018-2023)
    Figure 59. Middle East & Africa Anti-tumor Drug Market Size Market Share by Application (2018-2023)
    Figure 60. Egypt Anti-tumor Drug Market Size Growth 2018-2023 ($ Millions)
    Figure 61. South Africa Anti-tumor Drug Market Size Growth 2018-2023 ($ Millions)
    Figure 62. Israel Anti-tumor Drug Market Size Growth 2018-2023 ($ Millions)
    Figure 63. Turkey Anti-tumor Drug Market Size Growth 2018-2023 ($ Millions)
    Figure 64. GCC Country Anti-tumor Drug Market Size Growth 2018-2023 ($ Millions)
    Figure 65. Americas Anti-tumor Drug Market Size 2024-2029 ($ Millions)
    Figure 66. APAC Anti-tumor Drug Market Size 2024-2029 ($ Millions)
    Figure 67. Europe Anti-tumor Drug Market Size 2024-2029 ($ Millions)
    Figure 68. Middle East & Africa Anti-tumor Drug Market Size 2024-2029 ($ Millions)
    Figure 69. United States Anti-tumor Drug Market Size 2024-2029 ($ Millions)
    Figure 70. Canada Anti-tumor Drug Market Size 2024-2029 ($ Millions)
    Figure 71. Mexico Anti-tumor Drug Market Size 2024-2029 ($ Millions)
    Figure 72. Brazil Anti-tumor Drug Market Size 2024-2029 ($ Millions)
    Figure 73. China Anti-tumor Drug Market Size 2024-2029 ($ Millions)
    Figure 74. Japan Anti-tumor Drug Market Size 2024-2029 ($ Millions)
    Figure 75. Korea Anti-tumor Drug Market Size 2024-2029 ($ Millions)
    Figure 76. Southeast Asia Anti-tumor Drug Market Size 2024-2029 ($ Millions)
    Figure 77. India Anti-tumor Drug Market Size 2024-2029 ($ Millions)
    Figure 78. Australia Anti-tumor Drug Market Size 2024-2029 ($ Millions)
    Figure 79. Germany Anti-tumor Drug Market Size 2024-2029 ($ Millions)
    Figure 80. France Anti-tumor Drug Market Size 2024-2029 ($ Millions)
    Figure 81. UK Anti-tumor Drug Market Size 2024-2029 ($ Millions)
    Figure 82. Italy Anti-tumor Drug Market Size 2024-2029 ($ Millions)
    Figure 83. Russia Anti-tumor Drug Market Size 2024-2029 ($ Millions)
    Figure 84. Spain Anti-tumor Drug Market Size 2024-2029 ($ Millions)
    Figure 85. Egypt Anti-tumor Drug Market Size 2024-2029 ($ Millions)
    Figure 86. South Africa Anti-tumor Drug Market Size 2024-2029 ($ Millions)
    Figure 87. Israel Anti-tumor Drug Market Size 2024-2029 ($ Millions)
    Figure 88. Turkey Anti-tumor Drug Market Size 2024-2029 ($ Millions)
    Figure 89. GCC Countries Anti-tumor Drug Market Size 2024-2029 ($ Millions)
    Figure 90. Global Anti-tumor Drug Market Size Market Share Forecast by Type (2024-2029)
    Figure 91. Global Anti-tumor Drug Market Size Market Share Forecast by Application (2024-2029)

Roche
Novartis
Celgene
Bristol-Myers Squibb
Amgen
Johnson & Johnson
Pfizer
Takeda
Eli Lilly
AstraZeneca
Astellas
Merck & Co
Sanofi
Bayer
Biogen Idec
Eisai
Teva
Otsuka

LP Information presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

• Primary Source
  Players/Suppliers
  Industry Experts
  Distributors/Traders
  Opinion Leaders
  Front-line Staff
  Marketing Executives

  Secondary Source
  Journals and Periodicals
  Government Bodies
  Annual Reports
  Presentations
  Paid Databases
  LPI Internal Repository

• Data Synthesis
  Information Gathering
  Collation of Data
  Estimation of Key Figures
  Analysis of Derived Insights

  Data Validation
  Triangulation with Data Models
  Reference Against Proprietary
  Databases
  Corroboration with Industry Experts

• Qualitative Analysis
  Market drivers
  Market challenges
  Market trends
  Five forces analysis

  Qualitative Analysis
  Market size and forecast
  Market segmentation
  Geographical insights
  Competitive landscape